Skip to content
Home/Companies/HealthTech/Jeisys
JE

Jeisys

HealthTech·South Korea·Active·2yr hold

Jeisys is a consumer health company, headquartered in South Korea.

Entry
2024
Hold
2yr
Status
Active
Est. EV
–

Who owns Jeisys?

Jeisys is currently owned by ARCHIMED through MED Rise (2024 vintage), since 2024. Across its history, Jeisys has been through 2 private equity ownership periods, detailed in the timeline below.

Hand-verified · updated 2026-04-21

ARCHIMED
Most recent investor
ARCHIMED
MED Rise · 2024 · Buyout
2 ownership periods · full history below

Key facts

HQSouth Korea
SectorConsumer Health

Ownership history

2 ownership periods · co-invest detected

Active
Co-held by NiXEN and ARCHIMED since 2023.
Co-invest · 2 holders · 2023 · present
NiXEN
NiXENActive
2023 · present · NiXEN II · 2012 · Buyout
MOIC
–
ARCHIMED
ARCHIMEDActive
2024 · present · MED Rise · 2024 · Buyout
MOIC
–

More from MED Rise

Other portfolio companies in the same fund.

IRAB
Active
PharmaSpain· 2026
Arkstone
Active
HealthTechUS· 2025
Ceva Animal Health
Active
HealthcareFrance· 2025
ExcellGene
Active
BiotechSwitzerland· 2025
Groupe Laboratoire Rivadis
Active
HealthTechFrance· 2025
ZimVie
Active
MedTechUS· 2025

More PE-backed in HealthTech

Comparable healthtech deals from other GPs.

CIGA Healthcare
Active
Clarendon Fund ManagersUK
Paladin
Active
Ring CapitalFrance
Theraclion
Exited 2014
KaristaFrance
to
Access Infinity
Active
CBPE CapitalUK· 2026
Brightheart
Active
Odyssée VentureFrance· 2026
Dermascan
Active
Ring CapitalFrance· 2026
Data refreshed weekly · Sourced from public filings